Earnings Feed
Start Free
SUNESIS PHARMACEUTICALS INC·4

Jul 15, 4:11 PM ET

WARBURG PINCUS EQUITY PARTNERS LP 4

4 · SUNESIS PHARMACEUTICALS INC · Filed Jul 15, 2009

Insider Transaction Report

Form 4
Period: 2009-07-13
SUNESIS PHARMACEUTICALS INCSNSS
WARBURG PINCUS EQUITY PARTNERS LP
10% Owner
Transactions
  • Sale

    Common Stock, par value $0.0001 per share

    [F1][F2]
    2009-07-13$0.37/sh−350,000$130,410→ 3,954,075 total
  • Sale

    Common Stock, par value $0.0001 per share

    [F3][F2]
    2009-07-14$0.32/sh−107,300$34,390→ 3,846,775 total
Holdings

  • Common Stock Warrant

    [F2]
    Exercise: $6.21From: 2006-03-17Exp: 2013-03-17→ Common Stock, par value $0.0001 per share (241,546 underlying)
    241,546
Footnotes (3)
  • [F1]See Exhibit 99.1
  • [F2]See Exhibit 99.1
  • [F3]See Exhibit 99.1
Signature
WARBURG, PINCUS EQUITY PARTNERS, L.P. By: Warburg Pincus Partners, LLC, its General Partner, By: Warburg Pincus & Co., its Managing Member, By: /s/ Scott A. Arenare, Partner|2009-07-15

Documents

4 files